eMed
PrivateGLP-1 focused telehealth platform that partners with employers and government payers to manage GLP-1 medication usage for obesity and diabetes, building an agentic AI platform and capitated model to lower employer healthcare costs.
Founders Patrice Harris
CEO Patrice Harris
Company
Founded
2020
Headquarters
Miami, United States
Financials
Total Funding
$200M
Funding History
1 round Series A Mar 26, 2026
$200M Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.